Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
Similar to Pradaxa and Xarelto, Eliquis belongs to a new family of anticoagulants that do not have reversal agents to stop their blood-thinning effects during a bleeding event. As a result, it is believed that Eliquis patients may be at risk for serious, irreversible internal bleeding.
What is Eliquis?
Eliquis (apixaban) is a blood-thinning drug developed by Bristol-Meyers Squibb and Pfizer. Eliquis is administered to reduce the risk of blood clots for patients with atrial fibrillation (AFib), deep vein thrombosis (DVT), pulmonary embolism (PE), as well as people recovering from hip or knee replacement surgeries.
Eliquis, Pradaxa and Xarelto are seeking to gain a portion of the potential $10 billion market for this new type of pharmaceuticals. The prevailing treatment for decades has been warfarin (marketed under the name Coumadin). Eliquis doesn’t require the intensive monitoring that warfarin does.
Unlike warfarin, however, which has been generic for years and costs about $200 per year, Eliquis, Xarelto and Pradaxa can cost consumers thousands of dollars per patient in annual costs. Additionally, there is no commercial reversal agent available, which may lead to more serious and possibly harder to treat Eliquis side effects than with warfarin.
Eliquis Side Effects
Eliquis has recently been linked to internal bleeding and other serious side effects. These serious Eliquis internal bleeding events can be extremely difficult to treat. Warning signs and symptoms of internal bleeding may include:
- discolored urine (blood in the urine)
- red or black-colored stool
- vomiting or coughing up blood
- frequent nose bleeds or gum bleeding
- weakness and swelling in the extremities
- any other unusual bleeding
Eliquis is said to present less of a risk of bleeding in the brain than warfarin when given to AFib patients. The trouble is that, as with Pradaxa and Xarelto, Eliquis may cause more serious bleeding events in other regions of the body.
In turn, these bleeding events may be more difficult to treat. With warfarin, which thins the blood by blocking Vitamin K, administering a bleeding patient Vitamin K can serve as an antidote to a severe bleeding event. There is no such antidote for Eliquis.
Drug manufacturers, including the maker of Eliquis, are responsible for releasing safe and effective drugs into the marketplace. When these companies put the public at risk for serious injury by selling a defective drug, they can be held accountable through lawsuits.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Eliquis attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Eliquis class action lawsuit is best for you. [In general, Eliquis lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.
Get Help – It’s Free
Join a Free Eliquis Class Action Lawsuit Investigation
If you or a loved one took Eliquis (apixaban) and suffered injuries such as uncontrollable internal bleeding, gastrointestinal bleeding, hemorrhaging, kidney bleeding or death, you may have a legal claim. See if you qualify by filling out the short form below.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
Oops! We could not locate your form.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.